These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6266808)

  • 21. [In vitro assay for ACTH-releasing activity using ACTH radioimmunoassay: ACTH releasing activities by various drugs (author's transl)].
    Hashimoto K; Takahara J; Hosogi H; Ofuji N; Yasuhara T
    Nihon Naibunpi Gakkai Zasshi; 1976 Feb; 52(2):114-24. PubMed ID: 185101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of early glucocorticoid feedback by corticotropin-releasing factor in vitro.
    Shipston MJ; Antoni FA
    Endocrinology; 1992 Apr; 130(4):2213-8. PubMed ID: 1312450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
    Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro release of vasopressin and oxytocin from rat median eminence tissue.
    Verbalis JG; Baldwin EF; Ronnekleiv OK; Robinson AG
    Neuroendocrinology; 1986; 42(6):481-8. PubMed ID: 3703165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants.
    Costa A; Yasin SA; Hucks D; Forsling ML; Besser GM; Grossman A
    Endocrinology; 1992 Dec; 131(6):2595-602. PubMed ID: 1359961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.
    Caraty A; Grino M; Locatelli A; Guillaume V; Boudouresque F; Conte-Devolx B; Oliver C
    J Clin Invest; 1990 Jun; 85(6):1716-21. PubMed ID: 2161426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.
    Antoni FA; Fink G; Sheward WJ
    J Endocrinol; 1990 May; 125(2):175-83. PubMed ID: 2373973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergism between systemic corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin release in vivo varies as a function of gestational age in the ovine fetus.
    Norman LJ; Challis JR
    Endocrinology; 1987 Mar; 120(3):1052-8. PubMed ID: 3026785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress.
    Welt T; Engelmann M; Renner U; Erhardt A; Müller MB; Landgraf R; Holsboer F; Keck ME
    Neuropsychopharmacology; 2006 Dec; 31(12):2573-9. PubMed ID: 16395302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
    Vlaskovska M; Hertting G; Knepel W
    Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep.
    McFarlane A; Coghlan J; Tresham J; Wintour EM
    Endocrinology; 1995 May; 136(5):1821-7. PubMed ID: 7720626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfusion.
    Watanobe H; Takebe K
    Neuroendocrinology; 1994 Jul; 60(1):8-15. PubMed ID: 8090286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy.
    Holmes MC; Antoni FA; Catt KJ; Aguilera G
    Neuroendocrinology; 1986; 43(2):245-51. PubMed ID: 3487744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasopressin-containing and vasopressin-deficient subpopulations of corticotropin-releasing factor axons are differentially affected by adrenalectomy.
    Whitnall MH; Key S; Gainer H
    Endocrinology; 1987 May; 120(5):2180-2. PubMed ID: 3494595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin.
    Turkelson CM; Thomas CR; Arimura A; Chang D; Chang JK; Shimizu M
    Peptides; 1982; 3(2):111-3. PubMed ID: 6285317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat.
    Bruhn TO; Sutton SW; Plotsky PM; Vale WW
    Endocrinology; 1986 Oct; 119(4):1558-63. PubMed ID: 3019636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro release of ACTH by synthetic CRF.
    Turkelson CM; Arimura A; Culler MD; Fishback JB; Groot K; Kanda M; Luciano M; Thomas CR; Chang D; Chang JK; Shimizu M
    Peptides; 1981; 2(4):425-9. PubMed ID: 6276870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP; Clarke IJ; Funder JW; Engler D
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovine anterior pituitary proopiomelanocortin gene expression is not increased by ACTH secretagogues in vitro.
    Levin N; Wallace C; Bengani N; Blum M; Farnworth P; Smith AI; Roberts JL
    Endocrinology; 1993 Apr; 132(4):1692-700. PubMed ID: 8384993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.